MARIA RITA MACAPINLAC: Open Payments
NPI 1861915290 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 137 payments from 13 companies in 2025. Trend: 2023 $2,385 · 2024 $1,662 · 2025 $2,483
Food & beverage: $2,483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $618 |
| Teva Pharmaceuticals USA, Inc. | 40 | $505 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $399 |
| Alkermes, Inc. | 14 | $269 |
| Supernus Pharmaceuticals, Inc. | 14 | $163 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
| Lundbeck LLC | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $48 |
Products named: VRAYLAR, CAPLYTA, UZEDY, ARISTADA, REXULTI, Qelbree, AUSTEDO XR, COBENFY.
Industry payments across NY — which companies pay providers there.
